178 related articles for article (PubMed ID: 26895507)
41. Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.
Fangueiro JF; Andreani T; Egea MA; Garcia ML; Souto SB; Silva AM; Souto EB
Int J Pharm; 2014 Jan; 461(1-2):64-73. PubMed ID: 24275449
[TBL] [Abstract][Full Text] [Related]
42. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
Fangueiro JF; Andreani T; Fernandes L; Garcia ML; Egea MA; Silva AM; Souto EB
Colloids Surf B Biointerfaces; 2014 Nov; 123():452-60. PubMed ID: 25303852
[TBL] [Abstract][Full Text] [Related]
43. Nanocapsule of cationic liposomes obtained using "in situ" acrylic acid polymerization: stability, surface charge and biocompatibility.
Scarioti GD; Lubambo A; Feitosa JP; Sierakowski MR; Bresolin TM; de Freitas RA
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):267-72. PubMed ID: 21665442
[TBL] [Abstract][Full Text] [Related]
44. Novel biocompatible nanocapsules for slow release of fragrances on the human skin.
Hosseinkhani B; Callewaert C; Vanbeveren N; Boon N
N Biotechnol; 2015 Jan; 32(1):40-6. PubMed ID: 25224920
[TBL] [Abstract][Full Text] [Related]
45. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Swift S; Rupenthal I; Al-Kassas R
Pharm Dev Technol; 2016 Mar; 21(2):172-9. PubMed ID: 26794936
[TBL] [Abstract][Full Text] [Related]
46. Modular Approach for the Design of Smart Polymeric Nanocapsules.
Iyisan B; Landfester K
Macromol Rapid Commun; 2019 Jan; 40(1):e1800577. PubMed ID: 30507023
[TBL] [Abstract][Full Text] [Related]
47. Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application.
Lütfi G; Müzeyyen D
Pharm Dev Technol; 2013; 18(3):701-9. PubMed ID: 22813238
[TBL] [Abstract][Full Text] [Related]
48. Development and evaluation of injectable nanosized drug delivery systems for apigenin.
Karim R; Palazzo C; Laloy J; Delvigne AS; Vanslambrouck S; Jerome C; Lepeltier E; Orange F; Dogne JM; Evrard B; Passirani C; Piel G
Int J Pharm; 2017 Nov; 532(2):757-768. PubMed ID: 28456651
[TBL] [Abstract][Full Text] [Related]
49. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
50. Application of atomic force microscopy and ultrasonic resonator technology on nanoscale: distinction of nanoemulsions from nanocapsules.
Preetz C; Hauser A; Hause G; Kramer A; Mäder K
Eur J Pharm Sci; 2010 Jan; 39(1-3):141-51. PubMed ID: 19958830
[TBL] [Abstract][Full Text] [Related]
51. Tragacanth gum as a natural polymeric wall for producing antimicrobial nanocapsules loaded with plant extract.
Ghayempour S; Montazer M; Mahmoudi Rad M
Int J Biol Macromol; 2015 Nov; 81():514-20. PubMed ID: 26311653
[TBL] [Abstract][Full Text] [Related]
52. Role of the templating approach in influencing the suitability of polymeric nanocapsules for drug delivery: LbL vs SC/MS.
Goethals EC; Shukla R; Mistry V; Bhargava SK; Bansal V
Langmuir; 2013 Oct; 29(39):12212-9. PubMed ID: 23998648
[TBL] [Abstract][Full Text] [Related]
53. Nanobiotechnology and its applications in drug delivery system: a review.
Khan I; Khan M; Umar MN; Oh DH
IET Nanobiotechnol; 2015 Dec; 9(6):396-400. PubMed ID: 26647817
[TBL] [Abstract][Full Text] [Related]
54. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
55. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
56. Phenytoin-loaded lipid-core nanocapsules improve the technological properties and in vivo performance of fluidised bed granules.
de Oliveira EG; de Oliveira RS; Zatta KC; Furian AF; Oliveira MS; Pohlmann AR; Guterres SS; Beck RCR
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110753. PubMed ID: 32279762
[TBL] [Abstract][Full Text] [Related]
57. How Sorbitan Monostearate Can Increase Drug-Loading Capacity of Lipid-Core Polymeric Nanocapsules.
Poletto FS; De Oliveira CP; Wender H; Regent D; Donida B; Teixeira SR; Guterres SS; Rossi-Bergmann B; Pohlmann AR
J Nanosci Nanotechnol; 2015 Jan; 15(1):827-37. PubMed ID: 26328447
[TBL] [Abstract][Full Text] [Related]
58. Improving drug biological effects by encapsulation into polymeric nanocapsules.
Frank LA; Contri RV; Beck RC; Pohlmann AR; Guterres SS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(5):623-39. PubMed ID: 25641603
[TBL] [Abstract][Full Text] [Related]
59. Carbon nanotubes for stabilization of nanostructured lipid particles.
Gaunt NP; Patil-Sen Y; Baker MJ; Kulkarni CV
Nanoscale; 2015 Jan; 7(3):1090-5. PubMed ID: 25475215
[TBL] [Abstract][Full Text] [Related]
60. Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability.
Santander-Ortega MJ; Peula-García JM; Goycoolea FM; Ortega-Vinuesa JL
Colloids Surf B Biointerfaces; 2011 Feb; 82(2):571-80. PubMed ID: 21071187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
